GLOBUS MED INC's ticker is GMED and the CUSIP is 379577208. A total of 343 filers reported holding GLOBUS MED INC in Q3 2020. The put-call ratio across all filers is 0.45 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10,328,938 | +23.5% | 208,035 | +48.1% | 0.01% | +28.6% |
| Q2 2023 | $8,361,083 | -6.8% | 140,428 | -11.3% | 0.01% | -12.5% |
| Q1 2023 | $8,967,301 | -34.3% | 158,321 | -13.9% | 0.01% | -33.3% |
| Q4 2022 | $13,658,847 | +25.1% | 183,908 | +0.3% | 0.01% | +20.0% |
| Q3 2022 | $10,918,000 | +26.1% | 183,282 | +18.8% | 0.01% | +25.0% |
| Q2 2022 | $8,659,000 | -28.5% | 154,239 | -6.1% | 0.01% | -11.1% |
| Q1 2022 | $12,115,000 | +0.9% | 164,202 | -1.3% | 0.01% | +12.5% |
| Q4 2021 | $12,008,000 | -9.5% | 166,309 | -4.0% | 0.01% | -20.0% |
| Q3 2021 | $13,269,000 | -0.9% | 173,181 | +0.3% | 0.01% | 0.0% |
| Q2 2021 | $13,390,000 | +13.4% | 172,709 | -9.8% | 0.01% | +11.1% |
| Q1 2021 | $11,812,000 | -1.4% | 191,539 | +4.3% | 0.01% | 0.0% |
| Q4 2020 | $11,981,000 | +42.9% | 183,705 | +8.5% | 0.01% | +28.6% |
| Q3 2020 | $8,387,000 | +5.6% | 169,359 | +1.8% | 0.01% | -12.5% |
| Q2 2020 | $7,940,000 | +9.5% | 166,418 | -2.4% | 0.01% | -11.1% |
| Q1 2020 | $7,249,000 | -25.3% | 170,446 | +3.5% | 0.01% | 0.0% |
| Q4 2019 | $9,699,000 | +10.0% | 164,721 | -4.5% | 0.01% | 0.0% |
| Q3 2019 | $8,816,000 | +102.7% | 172,449 | +67.7% | 0.01% | +80.0% |
| Q2 2019 | $4,350,000 | -5.0% | 102,834 | +10.9% | 0.01% | -16.7% |
| Q1 2019 | $4,581,000 | -2.8% | 92,712 | -14.8% | 0.01% | -14.3% |
| Q4 2018 | $4,712,000 | -7.7% | 108,873 | +21.1% | 0.01% | 0.0% |
| Q3 2018 | $5,103,000 | +35.8% | 89,903 | +20.8% | 0.01% | +40.0% |
| Q2 2018 | $3,757,000 | -15.4% | 74,451 | -16.4% | 0.01% | -16.7% |
| Q1 2018 | $4,439,000 | +20.5% | 89,091 | -0.6% | 0.01% | +20.0% |
| Q4 2017 | $3,683,000 | +58.1% | 89,605 | +14.4% | 0.01% | +66.7% |
| Q3 2017 | $2,329,000 | -17.1% | 78,352 | -7.5% | 0.00% | -25.0% |
| Q2 2017 | $2,808,000 | +23.1% | 84,700 | +10.0% | 0.00% | 0.0% |
| Q1 2017 | $2,281,000 | +37.7% | 77,000 | +15.3% | 0.00% | +33.3% |
| Q4 2016 | $1,657,000 | -11.1% | 66,800 | -19.1% | 0.00% | 0.0% |
| Q3 2016 | $1,864,000 | -16.3% | 82,600 | -11.7% | 0.00% | -25.0% |
| Q2 2016 | $2,228,000 | +6.1% | 93,500 | +5.8% | 0.00% | +33.3% |
| Q1 2016 | $2,100,000 | -9.2% | 88,400 | +6.4% | 0.00% | -25.0% |
| Q4 2015 | $2,312,000 | +34.7% | 83,100 | 0.0% | 0.00% | +33.3% |
| Q3 2015 | $1,717,000 | -21.7% | 83,100 | -2.7% | 0.00% | 0.0% |
| Q2 2015 | $2,192,000 | -23.8% | 85,400 | -26.7% | 0.00% | -25.0% |
| Q1 2015 | $2,876,000 | 0.0% | 116,547 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $2,876,000 | +30.0% | 116,547 | +3.6% | 0.00% | +33.3% |
| Q3 2014 | $2,212,000 | -1.1% | 112,450 | +20.3% | 0.00% | 0.0% |
| Q2 2014 | $2,236,000 | -3.4% | 93,458 | 0.0% | 0.00% | 0.0% |
| Q1 2014 | $2,314,000 | +7131.2% | 93,458 | +5741.1% | 0.00% | – |
| Q4 2013 | $32,000 | -99.6% | 1,600 | -99.7% | 0.00% | -100.0% |
| Q3 2013 | $9,016,000 | +128700.0% | 516,385 | +128996.2% | 0.02% | – |
| Q2 2013 | $7,000 | – | 400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 589,100 | $45,137,000 | 24.71% |
| Sterling Investment Advisors, Ltd. | 188,123 | $14,414,000 | 4.29% |
| Godshalk Welsh Capital Management, Inc. | 73,748 | $5,651,000 | 3.52% |
| Pembroke Management, LTD | 601,447 | $46,083,000 | 3.47% |
| Integral Health Asset Management, LLC | 150,000 | $11,493,000 | 3.30% |
| XXEC, Inc. | 51,925 | $3,978,000 | 3.03% |
| PARADIGM CAPITAL MANAGEMENT INC/NY | 615,000 | $47,122,000 | 2.42% |
| Van Berkom & Associates Inc. | 946,997 | $72,559,000 | 2.20% |
| RTW INVESTMENTS, LP | 1,670,811 | $128,018,000 | 1.93% |
| Sivik Global Healthcare LLC | 95,000 | $7,279,000 | 1.74% |